Table 1.
Characteristics | Stimulation group (n = 11) | Sham group (n = 11) | Total (n = 22) | |
---|---|---|---|---|
Sex female, (%) | 85.7 | 88.9 | 87.5 | |
Age in y, mean (SD) | 63.09 ± 13.69 | 63.09 ± 8.71 | 63.09 ± 2.3 | |
Duration of illness in years, mean (SD) | 5.95 ± 7.29 | 6.20 ± 5.63 | 6.07 ± 1.35 | |
Medication, (%) | Pregabalin | 9.1 | 0 | 4.5 |
NSAR for facial pain | 0 | 18.2 | 9.1 | |
Antidepressant medication | 18.2 | 0 | 9.1 | |
Oral and maxillofacial disorders, (%) | None | 81.8 | 72.7 | 68.2 |
HO dental surgery | 9.1 | 27.3 | 18.2 | |
Craniomandibular dysfunction | 9.1 | 0 | 4.5 | |
Neurological disorder (%) | None | 63.6 | 72.7 | 68.2 |
Episodic migraine | 27.3 | 9.1 | 18.2 | |
Tinnitus | 9.1 | 9.1 | 9.1 | |
HO stroke | 0 | 9.1 | 4.5 | |
Diagnosed psychiatric disorders, (%) | None | 81.8 | 90.9 | 86.4 |
Depression | 18.2 | 0 | 9.1 | |
Somatic symptom disorder | 0 | 9.1 | 4.5 | |
Metabolic disorders, (%) | Morbus Fabry | 9.1 | 0 | 4.5 |
Hypothyroidism | 0 | 9.1 | 4.5 | |
Rheumatic diseases, (%) | Rheumatoid arthritis | 0 | 9.1 | 4.5 |
CREST-syndrome | 9.1 | 0 | 4.5 | |
Cardiovascular diseases, (%) | Arterial hypertension | 36.4 | 63.6 | 50 |
Musculoskeletal disorders, (%) | Spinal stenosis | 9.1 | 18.2 | 13.6 |
Herniated disc | 9.1 | 9.1 | 9.1 | |
Leg length discrepancy | 9.1 | 0 | 4.5 | |
Osteoarthritis | 9.1 | 0 | 4.5 | |
Gastrointestinal disorders, (%) | HO gastritis | 0 | 27.3 | 13.6 |
Gastroesophageal reflux | 18.2 | 0 | 9.1 | |
Gynecological Comorbidities, (%) | HO carcinoma | 0 | 18.2 | 9.1 |
HO hysterectomy | 18.2 | 0 | 9.1 | |
Chemotherapy, (%) | HO chemotherapy | 0 | 9.1 | 4.5 |
HO, “history of”.